Field Performance and Acceptability of the Hepatitis B Core-Related Antigen Rapid Diagnostic Test for Detecting High Viral Load Among Pregnant Women in The Gambia (PROTECT-B)
Clinical Infectious Diseases · 2026
DOI: 10.1093/cid/ciag311 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Alexandra M Famiglietti und 23 weiteren Autor:innen. Beteiligte Einrichtung: Institut Pasteur, Université Paris Cité, Unité d'Épidémiologie des Maladies Émergentes, Paris, France. Hauptthemen laut MEDLINE: Hepatitis B, Hepatitis B Core Antigens, Hepatitis B, Chronic, Pregnancy Complications, Infectious. Die Arbeit nennt 33 Literaturangaben. Gefördert von: ANRS-MIE, JSPS.
Abstract (Originalsprache)
Background
Mother-to-child transmission (MTCT) remains a major source of chronic hepatitis B virus (HBV) infection globally. Identifying pregnant women eligible for antiviral prophylaxis requires HBV DNA testing, which is often inaccessible in resource-limited settings. The hepatitis B core-related antigen rapid diagnostic test (HBcrAg-RDT) may offer a point-of-care alternative, yet prospective evaluation in antenatal care is lacking. We assessed its diagnostic performance, clinical impact, and user acceptability within a MTCT triple elimination program.
Methods
In this multicenter prospective cross-sectional study, treatment-naive, hepatitis B surface antigen (HBsAg)-positive pregnant women were enrolled across 4 antenatal services in The Gambia. HBcrAg-RDT diagnostic accuracy for detecting high viral load (≥200 000 IU/mL) was evaluated using plasma and capillary whole blood samples, with GeneXpert HBV viral load as the reference standard.
Results
Among 343 HBsAg-positive pregnant women, 5.5% had high viral load. The HBcrAg-RDT demonstrated sensitivities of 89.5% (95% CI 66.9–98.7) with plasma and 88.2% (63.6–98.5) with capillary blood, and specificities of 98.5% (96.4–99.5) and 98.7% (96.6–99.6), respectively. At 1 site implementing universal tenofovir prophylaxis, 77 women started treatment, of whom only 4 had HBV DNA ≥ 200 000 IU/mL. An HBcrAg-RDT–guided strategy would have identified all eligible women (4/4) while reducing unnecessary treatment from 100% (73/73) to 4.1% (3/73). Users rated RDT ease-of-use highly, although incubation time modestly increased workload.
Conclusions
The HBcrAg-RDT accurately identified pregnant women requiring antiviral prophylaxis and was accepted by users. It represents a feasible, lower-cost alternative to HBV DNA testing and may reduce unnecessary tenofovir use compared with universal prophylaxis strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut Pasteur, Université Paris Cité, Unité d'Épidémiologie des Maladies Émergentes, Paris, France.
- Medical Research Council Unit, The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia.
- Viruses, Hepatology, Cancer Team, INSERM U955, Créteil, France.
- National Hepatitis Control Program, Ministry of Health, Banjul, The Gambia.
- Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France.
- Faculty of Medicine, Imperial College London, London, United Kingdom.
ORCID-Profile: Alexandra M Famiglietti, Erwan Vo-Quang, Bakary Dibba, Sylvie Boyer, Saba Khan, Abdoul S E Tiendrebeogo, Umberto D'Alessandro, Yasuhito Tanaka, Gibril Ndow, Yusuke Shimakawa
Förderung
- ANRS-MIE
- JSPS
Zitieren
APA
Famiglietti, A. M., Drammeh, S., Vo-Quang, E., Dibba, B., Jammeh, K., Jallow, A. E., Touray, A. B., Keita, S., Gaye, Y., Manneh, B., Sallah, Y., Badjie, S., Boyer, S., Périères, L., Petitfour, L., Khan, S., Guingané, A. N., Tiendrebeogo, A. S. E., Kania, D., …, & Shimakawa, Y. (2026). Field Performance and Acceptability of the Hepatitis B Core-Related Antigen Rapid Diagnostic Test for Detecting High Viral Load Among Pregnant Women in The Gambia (PROTECT-B). Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag311
Vancouver
Famiglietti AM, Drammeh S, Vo-Quang E, Dibba B, Jammeh K, Jallow AE, et al. Field Performance and Acceptability of the Hepatitis B Core-Related Antigen Rapid Diagnostic Test for Detecting High Viral Load Among Pregnant Women in The Gambia (PROTECT-B). Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag311
BibTeX
@article{Famiglietti2026,
author = {Famiglietti, Alexandra M and Drammeh, Sainabou and Vo-Quang, Erwan and Dibba, Bakary and Jammeh, Kitabu and Jallow, Abdoulie E and Touray, Alhagie B and Keita, Saikou and Gaye, Yassin and Manneh, Baboucarr and Sallah, Yahya and Badjie, Sheriff and Boyer, Sylvie and Périères, Lauren and Petitfour, Laurène and Khan, Saba and Guingané, Alice N and Tiendrebeogo, Abdoul S E and Kania, Dramane and D'Alessandro, Umberto and Tanaka, Yasuhito and Lemoine, Maud and Ndow, Gibril and Shimakawa, Yusuke},
title = {Field Performance and Acceptability of the Hepatitis B Core-Related Antigen Rapid Diagnostic Test for Detecting High Viral Load Among Pregnant Women in The Gambia (PROTECT-B)},
journal = {Clinical Infectious Diseases},
year = {2026},
doi = {10.1093/cid/ciag311}
}
EUVIMED